glp-1 and dual glp-1/gip receptor agonists Major physiological roles of GIP. Tirzepatide is acting as an Tirzepatide's Unique Mechanism of Action
Description
[16] Microdosing Tirzepatide: The Single-Dose Barrier Microdosing tirzepatide (Mounjaro/Zepbound) is much harder
If Phase 3 trials confirm these results, retatrutide could significantly shift the treatment paradigm
Participants receiving tirzepatide achieved greater weight-loss milestones than those receiving semaglutide [3]
Bone, body weight, and weight reduction: what are the concerns
Recent advances in incretin-based therapy for MASLD: From single to dual or triple incretin receptor agonists
It is a dual GLP-1 and GIP receptor agonist , meaning it acts on two hormones instead of one
